| Literature DB >> 27418946 |
Wenjian Xie1, Hongjie Zhang1, Jianguo Zeng2, Hubiao Chen1, Zhongzhen Zhao1, Zhitao Liang1.
Abstract
BACKGROUND: The dry root of Salvia miltiorrhiza Bunge (Danshen in Chinese) is an used-widely traditional Chinese herbal medicine with and promising efficacy. This herbal plant has been extensively cultivated in China. Currently, people usually rely on its morphological features to evalaute its pharmaceutical quality. In this study, laser micro-dissection system (LMD) was applied to isolate single fresh tissue of root of S. miltiorrhiza. Under fluorescent microscopic model, five tissues namely cork, cortex, phloem, xylem ray and vessel were well recognized and isolated accurately by LMD, respectively and then the distribution pattern of the major bioactive compounds in various tissues was investigated by ultra-performance liquid chromatography-quadrupole/time of flight-mass spectrometry, which aims to validate the traditional experience on evaluating pharmaceutical quality of Danshen by morphological features.Entities:
Keywords: Pharmaceutical quality evaluation; Salvia miltiorrhiza Bunge; Salvianolic acids; Tanshinones; Tissues-based analysis
Year: 2016 PMID: 27418946 PMCID: PMC4944434 DOI: 10.1186/s13065-016-0187-7
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Sample information of S. miltiorrhiza in the present study
| Sample no. | Colour of outer barka | Sizeb (cm) | Sources | Collection date |
|---|---|---|---|---|
| S1 | Brownish–red | 0.8 | Cultivation, Zhongjiang County, Sichuan province | 2014.11.19 |
| S2 | Dark brownish–red | 1.3 | Cultivation, Shangluo City, Shanxi province | 2014.11.19 |
| S3 | Dark brownish–red | 0.75 | Cultivation, Fangcheng County, Henan province | 2014.11.19 |
| S4 | Brownish–red | 1.4 | Wild, Henan province | 2014.11.19 |
| S5 | Brownish–red | 0.7 | Cultivation, Linqu County, Shandong province | 2014.11.19 |
| S6 | Brownish–red | 1.0 | Cultivation, Beijing | 2014.11.19 |
| S7 | Brownish–red | 0.5 | Cultivation, Beijing | 2014.11.19 |
| S8 | Brownish–red | 0.65 | Cultivation, Beijing | 2014.11.19 |
| S9 | Brownish–red | 1.0 | Cultivation, Nanjing, Jiangsu province | 2015.05.31 |
aColour of outer bark refer to Fig. 6
bSize calculated by diameter of main root of S. miltiorrhiza
Fig. 6The appearance of 9 research samples (S1–S9, from left to right)
Fig. 1Chemical structures of 5 chemical markers
Total micro-dissected area in different tissues
| Sample no. | Special tissue/total micro-dissected area (μm2) | ||||
|---|---|---|---|---|---|
| Cork | Cortex | Phloem | Xylem ray | Vessel | |
| S1 | 1,006,611 | 1,003,330 | 1,063,204 | 1,022,559 | 1,020,931 |
| S2 | 1,000,990 | 1,000,072 | 1,000,320 | 1,000,791 | 1,000,276 |
| S3 | 1,000,160 | 1,003,816 | 1,000,051 | 1,000,830 | 1,000,686 |
| S4 | 1,000,011 | 1,000,962 | 1,000,249 | 1,000,343 | 1,000,589 |
| S5 | 1,000,583 | 1,000,699 | 1,000,983 | 1,000,300 | 1,000,349 |
| S6 | 1,000,736 | 1,001,599 | 1,000,860 | 1,001,172 | 1,000,058 |
| S7 | 1,003,180 | 1,000,194 | 1,000,901 | 1,000,148 | 1,001,122 |
| S8 | 1,000,609 | 1,000,606 | 1,000,728 | 1,000,407 | 1,000,354 |
| S9 | 1,000,402 | 1,000,365 | 1,000,629 | 1,000,310 | 1,000,291 |
Fig. 2Cross-sections of the root of S. miltiorrhiza (S7) a observed under the bright filed mode b observed under the fluorescent mode
Fig. 3The represent BPC chromatograms from cork tissue of S1 and S2 detected under positive mode (a), cork tissue of S1 and cortex tissue of S5 (b) as well as cork tissue of S2 and S5 (c) detected under negative mode.1 SP solvent peak
Characteristics of bioactive components in various tissues
| Peak no.a | Rt (min) | Polarity | Formula | Identification |
|---|---|---|---|---|
| 1 | 2.63 | 313.0718 [M−H]− | C17H14O6 | Salvianolic acid Fb |
| 2 | 3.59 | 535.1818 [M−H]− | C26H32O12 | (+)1-hydroxypinoresinol-1-O-β-D-glucosideb |
| 3 | 3.96 | 359.0732 [M−H]− | C18H16O8 | Rosmarinic acidb |
| 4 | 4.43 | 717.1406 [M−H]− | C36H30O16 | Salvianolic acid Bc |
| 5 | 4.56 | 137.0242 [M−H]− | C7H6O3 | Protocatechualdehydeb |
| 6 | 4.98 | 193.0479 [M−H]− | C10H10O4 | Ferulic acidb |
| 7 | 6.04 | 335.0894 [M+Na]+, 313.1071 [M+H]+ | C18H16O5 | Tanshindiol Cb |
| 8 | 7.18 | 297.1118 [M−H]− | C19H22O3 | Arucadiolb |
| 9 | 7.40 | 319.0944 [M+Na]+, 297.1124 [M+H]+ | C18H16O4 | Danshenxinkunb |
| 10 | 7.63 | 117.0193 [M−H]− | C4H6O4 | Succinic acidb |
| 11 | 7.77 | 357.0588 [M−H]− | C18H14O8 | Prolithospermic acidb |
| 12 | 7.84 | 335.1252 [M + Na]+, 313.1432 [M+H]+ | C19H20O4 | Miltionone IIb |
| 13 | 8.99 | 317.0786 [M+Na]+, 295.0969 [M+H]+ | C18H14O4 | Trijuganone Ab |
| 14 | 9.12 | 319.0944 [M+Na]+, 297.1124 [M+H]+ | C18H16O4 | Tanshinone VIb |
| 15 | 9.27 | 383.9794 [M−H]− | Unknown | |
| 16 | 9.98 | 333.1097 [M+Na]+, 311.1279 [M+H]+ | C19H18O4 | Isotanshinoneb |
| 17 | 10.07 | 303.0996 [M+Na]+, 281.1162 [M+H]+ | C18H16O3 | Methylene dihydrotanshinoneb |
| 18 | 10.21 | 335.1252 [M+Na]+, 313.1434 [M+H]+ | C19H20O4 | Miltionone Ib |
| 19 | 10.35 | 491.1039 [M−H]− | C26H20O10 | Salvianolic acid Cb |
| 20 | 10.41 | 333.1098 [M+Na]+, 311.1282 [M+H]+ | C19H18O4 | Tanshinone IIBb |
| 21 | 10.64 | 333.1100 [M+Na]+, 311.1282 [M+H]+ | C19H18O4 | 3α-hydroxytanshinone IIA/3β-hydroxytanshinone IIAb |
| 22 | 10.87 | 333.1099 [M+Na]+, 311.1283 [M+H]+ | C19H18O4 | 3α-hydroxytanshinone IIA/3β-hydroxytanshinone IIAb |
| 23 | 10.98 | 327.0872 [M−H]− | C18H16O6 | Methylsalvianolate Fb |
| 24 | 11.38 | 363.1202 [M+Na]+, 341.1380 [M+H]+ | C20H20O5 | Cryptomethyltanshinoateb |
| 25 | 11.57 | 295.0958 [M−H]− | C18H16O4 | Tanshinol Bb |
| 26 | 11.75 | 325.1079 [M−H]− | C14H14O9 | Monocaffeoyltartaric acidb |
| 27 | 12.01 | 285.1853 [M−H]− | C20H30O | Ferruginolb |
| 28 | 12.02 | 309.1125 [M+Na]+, 287.1642 [M+H]+ | C18H22O3 | Epicryptoacetalide/Cryptoacetalideb |
| 29 | 12.18 | 487.3401 [M−H]− | Unknown | |
| 30 | 12.24 | 309.1125 [M+Na]+, 287.2002 [M+H]+ | C18H22O3 | Epicryptoacetalide/Cryptoacetalideb |
| 31 | 12.35 | 313.1438 [M−H]− | C19H22O4 | Tanshinone Vb |
| 32 | 12.38 | 301.0838 [M+Na]+, 279.1016 [M+H]+ | C18H14O3 | Methylenetanshinquinoneb |
| 33 | 12.46 | 485.3274 [M−H]− | Unknown | |
| 34 | 12.57 | 537.1038 [M−H]− | C27H22O12 | Lithospermic acidb |
| 35 | 12.82 | 293.0819 [M−H]− | C18H14O4 | 3-hydroxymethylenetanshinoneb |
| 36 | 12.88 | 321.1646 [M+Na]+, 299.1642 [M+H]+ | C19H22O3 | Miltiodiolb |
| 37 | 12.96 | 555.3268 [M−H]− | Unknown | |
| 38 | 13.00 | 301.0834 [M+Na]+, 279.1015 [M+H]+ | C18H14O3 | Dihydrotanshinone Ic |
| 39 | 13.11 | 301.0834 [M+Na]+, 279.1015 [M+H]+ | C18H14O3 | 1,2-dihydrotanshinone Ib |
| 40 | 13.16 | 329.1750 [M−H]− | C20H26O4 | Salviolb |
| 41 | 13.41 | 319.1306 [M+Na]+, 297.1491 [M+H]+ | C19H20O3 | Isocryptotanshinoneb |
| 42 | 13.84 | 303.0998 [M+Na]+, 281.1173 [M+H]+ | C18H16O3 | Danshenxinkun Bb |
| 43 | 14.25 | 361.1045 [M+Na]+, 339.1230 [M+H]+ | C20H18O5 | Methyl tanshinoateb |
| 44 | 14.32 | 357.0616 [M−H]− | C18H14O8 | Prolithospermic acidb |
| 45 | 14.62 | 333.1089 [M+Na]+, 301.1800 [M+H]+ | C19H24O3 | Miltipoloneb |
| 46 | 14.75 | 265.1470 [M−H]− | C18H18O2 | Methylenemiltironeb |
| 47 | 15.45 | 315.0846 [M−H]− | C17H16O6 | 5,3′-dihydroxy-7,4′-dimethoxyflavanoneb |
| 48 | 15.97 | 299.0684 [M+Na]+, 277.0867 [M+H]+ | C18H12O3 | Tanshinone Ic |
| 49 | 16.00 | 319.1307 [M+Na]+, 297.1488 [M+H]+ | C19H20O3 | Cryptotanshinonec |
| 50 | 16.15 | 315.1949 [M−H]− | C20H28O3 | 1-phenanthrenecarboxylic acidb |
| 51 | 16.35 | 297.1830 [M−H]− | C20H26O2 | 5-dehydrosugiolb |
| 52 | 16.64 | 299.2018 [M−H]− | C20H28O2 | Sugiolb |
| 53 | 16.79 | 299.0684 [M+Na]+, 277.0867 [M+H]+ | C18H12O3 | Isotanshinone Ib |
| 54 | 17.25 | 301.0834 [M+Na]+, 279.1015 [M + H]+ | C18H14O3 | Dihydroisotanshinone Ib |
| 55 | 17.75 | 315.1001 [M+Na]+, 293.1179 [M+H]+ | C19H16O3 | 1,2 -didehydrotanshinone IIAb |
| 56 | 18.18 | 289.1204 [M+Na]+, 267.1386 [M+H]+ | C17H14O3 | Dihydrotanshinlactoneb |
| 57 | 18.87 | 303.1306 [M+Na]+, 281.1539 [M+H]+ | C19H20O2 | Δ1 -dehydromiltironeb |
| 58 | 19.13 | 325.1824 [M−H]− | C21H26O3 | 2-(7-Dihydroxyl)-benzofuranyl-,ferulic acidb |
| 59 | 19.30 | 317.1158 [M+Na]+, 295.1333 [M+H]+ | C19H18O3 | Tanshinone II Ac |
| 60 | 20.01 | 317.1151 [M+Na]+, 295.1332 [M+H]+ | C19H18O3 | Isotanshinone II Ab |
| 61 | 20.39 | 305.1515 [M+Na]+, 283.1700 [M+H]+ | C19H22O2 | Miltironeb |
| 62 | 21.31 | 683.4317 [M−H]− | C44H60O6 | 3,4-Dihydroxy-(1α,3α,4α,5β)-1-carboxy-4-hydroxy-1,3,5-cyclohexanetriyl ester-benzenepropanoicb |
R retention time
aThe peak numbers referred to Fig. 3
bIdentified by previously reported from Salvia species
cIdentified by chemical markers
Fig. 4The profile of chemicals in various tissues from S1 to S9
The distribution of bioactive components in various tissues from different samples
| Sample no. | Herbal tissues/peak No.a | ||||
|---|---|---|---|---|---|
| Cork | Cortex | Phloem | Xylem ray | Vessel | |
| S1 | 3, 4, 8, 9, 12–14, 16–22, 24–39, 41–57, 59–61 | 9, 17, 32, 36, 38, 39, 41, 46, 48, 49, 53 | 9, 17, 24, 32, 36, 38, 39, 41, 42, 46, 48, 49, 53, 54, 59 | 9, 17, 20, 32, 36, 38, 39, 41–43, 48, 49, 53, 54, 59, 61 | 10, 14, 32, 36, 38, 39, 41, 46, 48, 49, 53, 54, 59 |
| S2 | 4, 6, 7, 9, 17, 20, 24, 28, 31, 32, 36, 38, 39, 41–43, 45, 46, 48, 49, 52–56, 59, 61 | 9, 32, 36, 38, 39, 41, 48 49, 53, 54 | 9, 32, 36, 38, 39, 41, 48, 49, 53, 54 | 9, 17, 23, 28, 32, 36, 38, 39, 41, 48, 49, 53, 54 | 9, 17, 24, 28, 32, 36, 38, 39, 41, 48, 49, 53, 54 |
| S3 | 4, 9, 12–14, 16–18, 20–22, 24, 28, 30, 32, 36, 38, 39, 41–43, 45, 48, 49, 51–55, 59, 61, 62 | 9, 17, 22, 32, 38, 39, 41 48, 49, 53, 54 | 9, 32, 38, 39, 41, 48, 49, 53, 54 | 9, 32, 38, 39, 41, 48, 49, 53, 54 | 9, 17, 24, 28, 32, 38, 39, 41, 48, 49, 53, 54 |
| S4 | 4, 5, 9, 14, 20, 30, 32, 36, 38, 39, 41–43, 45, 48, 49, 53–55, 59, 61 | 9, 14, 20, 32, 38, 39, 41 48, 49, 53, 54 | 9, 17, 32, 38, 39, 41, 48, 49, 53, 54 | 9, 32, 38, 39, 41, 48, 49, 53, 54 | 9, 32, 38, 39, 41, 48, 49, 53, |
| S5 | 4, 14, 16, 20, 23, 30, 32, 36, 38, 39, 41–46, 48, 49, 52, 54, 55, 59, 61, 62 | 1–5, 9–11, 14, 15, 17, 22–24, 28, 32, 36, 38, 39, 41, 48, 49, 53, 58 | 9, 17, 22, 24, 28, 32, 38, 39, 41, 46, 48, 49, 53 | 16, 24, 39 | 9, 10, 32, 38, 39, 41, 48, 49, 53, 54, 59 |
| S6 | 4, 23, 30, 32, 38, 39, 41, 42, 46, 48, 49, 54, 59, 61 | 9, 23, 24, 30, 32, 36, 38, 39, 41, 49 | 23, 24, 30, 32, 38, 39, 41, 46, 48 | 9, 23, 24, 30, 32, 38, 39, 41, 46 | 23, 30, 32, 36, 38, 39, 41, 46 |
| S7 | 4, 12, 14, 16, 18, 20, 23, 24, 30, 32, 36, 38, 41–43, 45, 46, 48–50, 52, 54, 59, 61 | 9, 16, 23, 24, 30, 32, 37–39, 41, 42, 45, 48, 49, 53 | 9, 23, 24, 30, 32, 38, 39, 41, 46, 49, 63 | 9, 23, 24, 30, 32, 38, 39, 41, 49 | 23, 30, 32, 38, 39, 41, 49 |
| S8 | 4, 12, 14, 16, 18, 20, 23, 24, 30, 32, 36, 38, 41–43, 45, 48–50, 52, 54, 59, 61 | 4, 23, 24, 30, 32, 38, 39, 41, 49 | 23, 24, 30, 32, 36, 38, 39, 41, 46, 49 | 23, 30, 32, 38, 39 | 4, 23, 30, 32, 38, 39, 49 |
| S9 | 4, 12, 17, 22–33, 35, 37–42, 48, 49, 59 | 23, 30, 32, 36, 38, 39, 41 | 23, 30, 32, 36, 38, 39, 41 | 23, 30, 32, 38, 39 | 23, 30, 32, 36, 38, 39, 41 |
aThe peak numbers referred to Table 3 and Fig. 3
Methodological validation data of chemical markers
| Chemical markers | Calibration curve | R2 | LOD (ng/mL) | LOQ (ng/mL) |
|---|---|---|---|---|
| Sa B | Y = 34.82X−5199.5 | 0.9997 | 44.31 | 75.00 |
| DHTan I | Y = 903.46X+2021.7 | 0.9996 | 3.88 | 12.90 |
| Tan I | Y = 245.31X+1718.4 | 0.9997 | 3.73 | 12.42 |
| CTan | Y = 1410.80X+1063.5 | 1.0000 | 3.87 | 12.89 |
| Tan II A | Y = 1531.80X+12447 | 0.9998 | 8.03 | 26.74 |
Fig. 5Methodological validation data of chemical markers
Fig. 7A loading plot obtained from principal component analysis of the contents of major tanshinones contained in different tissues from all of samples